The International Conference on “Transforming Northeast India from Biodiversity Hotspot to Biomanufacturing Hotspot: A BioE3 Perspective” was held at Assam Royal Global University, emphasizing Northeast India’s significant biodiversity as a catalyst for the region’s bioeconomy and growth of biomanufacturing industries. Dr. Srinivas V. Kaveri, Director of Research at INSERM in Paris, delivered the keynote address, outlining the importance of the immune response and the role of Intravenous Immunoglobulin (IVIG) therapy in modern medicine. He underscored the need for a robust plasma industry to advance immunotherapy and biotechnological innovations, highlighting regular blood donation as essential for supporting medical advancements. Dr. Kaveri stressed that the vast, untapped biodiversity potential of Northeast India could play a pivotal role in the bioeconomy, guiding future healthcare efforts through biotechnology. Prof. A. K. Buragohain, Vice Chancellor of RGU, supported this view, asserting that Northeast India should strategically utilize its ecological resources to achieve sustainable bioeconomic growth, and predicted that biotechnology will be a cornerstone of future technological development. The conference, sponsored by the Anusandhan National Research Foundation and the Defence Research and Development Organisation, gathered leading scientists, academicians, and industry experts to discuss the BioE3 Policy, which focuses on enhancing India’s biomanufacturing sector through innovation, sustainability, and superior production quality.
Future of Bioeconomy Lies in E-Biodiversity: INSERM–Paris Director
